• Erie JC, Good JA, Butz JA.

Excess Lead in the Neural Retina in Age-related Macular Degeneration.
Am J Ophthalmol 2009.

• Ahn JK, Moon HJ.

Changes in Aqueous Vascular Endothelial Growth Factor and Pigment Epithelium-derived Factor after Ranibizumab Alone or Combined with Verteporfin for Exudative Age-related Macular Degeneration.
Am J Ophthalmol 2009.

• Csaky K, Do DV.

Safety Implications of Vascular Endothelial Growth Factor Blockade for Subjects Receiving Intravitreal Anti-Vascular Endothelial Growth Factor Therapies.
Am J Ophthalmol 2009.

• Wong TY.

Age-related macular degeneration and cardiovascular disease in the era of anti-vascular endothelial growth factor therapies.
Am J Ophthalmol 2009;148:327-9.

• Byeon SH, Chu YK.

Interpretation of fovea center morphologic features in optical coherence tomography.
Am J Ophthalmol 2009;148:474-5; author reply 475.

• Khan K, Khan R, Rahman R.

Macular hole surgery with inner limiting membrane peeling.
Am J Ophthalmol 2009;148:323; author reply 324.

• Romanelli RG, Almerigogna F.

Uveitis as a presenting feature of autoimmune hepatitis.
Am J Ophthalmol 2009;148:318-9; author reply 319-20.

• Gaudio PA.

Ranibizumab for uveitic macular edema: why?
Am J Ophthalmol 2009;148:179-80.

• Cohen SY, Fung AE, Tadayoni R, Massin P, Barbazetto I, Berthout A, Gayet P, Meunier I, Yannuzzi LA.

Unilateral Retinal Pigment Epithelium Dysgenesis.
Am J Ophthalmol 2009.

• Sinsheimer J.

Statistical genetic approaches for mapping ophthalmic trait and disease genes.
Am J Ophthalmol 2009;148:183-5.

• Scott IU, Oden NL, Vanveldhuisen PC, Ip MS, Blodi BA, Antoszyk AN.

Standard Care vs Corticosteroid in Retinal Vein Occlusion Study Report 7: Incidence of Intravitreal Silicone Oil Droplets Associated With Staked-on vs Luer Cone Syringe Design.
Am J Ophthalmol 2009.

• Ying GS, Maguire MG, Alexander J, Martin RW, Antoszyk AN.

Description of the Age-Related Eye Disease Study 9-step severity scale applied to participants in the Complications of Age-related Macular Degeneration Prevention Trial.
Arch Ophthalmol 2009;127:1147-51.

• Heindl LM, Mardin CY, Holbach LM, Naumann GO, Kruse FE, Knorr HL.

Vitreal seeding from uveal melanoma detected by high-resolution spectral-domain optical coherence tomography.
Arch Ophthalmol 2009;127:1062-4.

• Shields CL, Furuta M, Berman EL, Zahler JD, Hoberman DM, Dinh DH, Mashayekhi A, Shields JA.

Choroidal nevus transformation into melanoma: analysis of 2514 consecutive cases.
Arch Ophthalmol 2009;127:981-7.

• Lindblad AS, Lloyd PC, Clemons TE, Gensler GR, Ferris FL, 3rd, Klein ML, Armstrong JR.

Change in area of geographic atrophy in the Age-Related Eye Disease Study: AREDS report number 26.
Arch Ophthalmol 2009;127:1168-74.

• Chua PY, Mitrut I, Armbrecht AM, Vani A, Aslam T, Dhillon B.

Evaluating patient discomfort, anxiety, and fear before and after ranibizumab intravitreous injection for wet age-related macular degeneration.
Arch Ophthalmol 2009;127:939-40.

• Sohn EH, Francis PJ, Duncan JL, Weleber RG, Saperstein DA, Farrell DF, Stone EM.

Phenotypic variability due to a novel Glu292Lys variation in exon 8 of the BEST1 gene causing best macular dystrophy.
Arch Ophthalmol 2009;127:913-20.

• Apte RS.

SCOREing in retinal venous occlusive disease.
Arch Ophthalmol 2009;127:1203-4.

• Klein BE, Knudtson MD, Tsai MY, Klein R.

The relation of markers of inflammation and endothelial dysfunction to the prevalence and progression of diabetic retinopathy: Wisconsin epidemiologic study of diabetic retinopathy.
Arch Ophthalmol 2009;127:1175-82.

• Scott IU, Ip MS, VanVeldhuisen PC, Oden NL, Blodi BA, Fisher M, Chan CK, Gonzalez VH, Singerman LJ, Tolentino M.

A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with standard care to treat vision loss associated with macular Edema secondary to branch retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report 6.
Arch Ophthalmol 2009;127:1115-28.

• Ip MS, Scott IU, VanVeldhuisen PC, Oden NL, Blodi BA, Fisher M, Singerman LJ, Tolentino M, Chan CK, Gonzalez VH.

A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with observation to treat vision loss associated with macular edema secondary to central retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report 5.
Arch Ophthalmol 2009;127:1101-14.

• Tang Z, Wang Z, Ke T, Wang QK, Liu M.

Novel compound heterozygous mutations in CERKL cause autosomal recessive retinitis pigmentosa in a nonconsanguineous Chinese family.
Arch Ophthalmol 2009;127:1077-8.

• Dimaras H, Khetan V, Halliday W, Heon E, Chan HS, Gallie BL.

Retinoma underlying retinoblastoma revealed after tumor response to 1 cycle of chemotherapy.
Arch Ophthalmol 2009;127:1066-8.

• Mitry D, Constable I, Singh J.

Photoreceptor outer segment glaucoma in rhegmatogenous retinal detachment.
Arch Ophthalmol 2009;127:1053-4.

• Cuenca A, Giron F, Castro D, Fandino A, Guitter M, de Davila MT, Chantada G.

Microscopic scleral invasion in retinoblastoma: clinicopathological features and outcome.
Arch Ophthalmol 2009;127:1006-10.

• Spaide RF.

Potential causes of altered autofluorescence in diabetic persons.
Arch Ophthalmol 2009;127:942-3; author reply 943-4.

• Lincoff H.

The evolution of retinal surgery: a personal story.
Arch Ophthalmol 2009;127:923-8.

• Pearlman RB, Golchet PR, Feldmann MG, Yannuzzi LA, Cooney MJ, Thorne JE, Folk JC, Ryan EH, Agarwal A, Barnes KC, Becker KG, Jampol LM.

Increased prevalence of autoimmunity in patients with white spot syndromes and their family members.
Arch Ophthalmol 2009;127:869-74.

• Rajak SN, Mohamed MD, Pelosini L.

Further insight into West African crystalline maculopathy.
Arch Ophthalmol 2009;127:863-8.

• Lim MC, Tanimoto SA, Furlani BA, Lum B, Pinto LM, Eliason D, Prata TS, Brandt JD, Morse LS, Park SS, Melo LA, Jr.

Effect of diabetic retinopathy and panretinal photocoagulation on retinal nerve fiber layer and optic nerve appearance.
Arch Ophthalmol 2009;127:857-62.

• Renner AB, Fiebig BS, Cropp E, Weber BH, Kellner U.

Progression of retinal pigment epithelial alterations during long-term follow-up in female carriers of choroideremia and report of a novel CHM mutation.
Arch Ophthalmol 2009;127:907-12.

• Kesen MR, Edward DP, Rao NA, Sugar J, Tessler HH, Goldstein DA.

Atypical infectious nodular scleritis.
Arch Ophthalmol 2009;127:1079-80.

• Chen YJ, Chen JT, Lu DW, Gao HW, Tai MC.

Primary peripheral T-cell lymphoma of the orbit.
Arch Ophthalmol 2009;127:1070-2.

• Hayreh SS.

Pathogenesis of nonarteritic anterior ischemic optic neuropathy.
Arch Ophthalmol 2009;127:1082-3; author reply 1083-4.

• Lott MN, Schiffman JC, Davis JL.

Bevacizumab in Inflammatory Eye Disease.
Am J Ophthalmol 2009.

• Lopez-Guajardo L, Benitez-Herreros J, Teus-Guezala M.

Optical coherence tomography as a method for studying sutureless microincisional vitrectomy sclerotomies.
Am J Ophthalmol 2009;148:321-2; author reply 322-3.

• Caramoy A, Liakopoulos S, Menrath E, Kirchhof B.

Autologous translocation of choroid and retinal pigment epithelium in geographic atrophy: Long term functional and anatomical outcome.
Br J Ophthalmol 2009.

• Dell'omo R, Wong R, Konstantopoulou K, Marino M, Pavesio CE.

Relationship between different fluorescein and indocyanine green angiography features in multiple evanescent white dot syndrome.
Br J Ophthalmol 2009.

• Mulder DJ, Bieze M, Graaff R, Smit A, Hooymans A.

Skin Autofluorescence is Elevated in Neovascular Age-Related Macular Degeneration.
Br J Ophthalmol 2009.

• Bolz M, Simader C, Ritter M, Ahlers C, Benesch T, Pruente C, Schmidt-Erfurth UM.

Morphological and functional analysis of the loading regimen with intravitreal ranibizumab in neovascular AMD.
Br J Ophthalmol 2009.

• Awdeh RM, Elsing SH, Deramo VA, Stinnett S, Lee PP, Fekrat S.

Vision-related quality of life in persons with branch retinal vein occlusion (BRVO) using the 25-item NEI Visual Function Questionnaire.
Br J Ophthalmol 2009.

• Goold LA, Edussuriya K, Sennanayake S, Senaratne T, Selva D, Sullivan T, Casson RJ.

Prevalence and determinants of ARMD in central Sri Lanka: The Kandy Eye Study.
Br J Ophthalmol 2009.

• Fawzi AA, Lee NG, Eliott D, Song J, Stewart JM.

Retinal Findings in Patients with Alport Syndrome: Expanding the Clinical Spectrum.
Br J Ophthalmol 2009.

• McMahon A, Kedzierski W.

Polyunsaturated extremely long chain C28-C36 fatty acids and retinal physiology.
Br J Ophthalmol 2009.

• De Zaeytijd J, Vanakker OM, Coucke PJ, De Paepe A, De Laey JJ, Leroy BP.

Added Value of Infrared, Red-free and Autofluorescence Fundus Imaging in Pseudoxanthoma Elasticum.
Br J Ophthalmol 2009.

• Vom Hagen F, Kamppeter BA, Erber R, Jonas J, Hammes HP.

Intravitreal thalidomide reduces experimental preretinal neovascularization without induction of retinal toxicity.
Br J Ophthalmol 2009.

• MacCarthy A, Bayne AM, Draper GJ, Eatock EM, Kroll ME, Stiller CA, Vincent TJ, Hawkins MM, Jenkinson HC, Kingston JE, Neale R, Murphy MF.

Non-ocular tumours following retinoblastoma in Great Britain 1951 to 2004.
Br J Ophthalmol 2009;93:1159-62.

• Kivela T.

The epidemiological challenge of the most frequent eye cancer: retinoblastoma, an issue of birth and death.
Br J Ophthalmol 2009;93:1129-31.

• Kellner S, Weinitz S, Kellner U.

Spectral domain optical coherence tomography detects early stages of chloroquine retinopathy similar to multifocal electroretinography, fundus autofluorescence and near-infrared autofluorescence.
Br J Ophthalmol 2009.

• Van Aken EH, De Letter EA, Veckeneer M, Derycke L, Van Enschot T, Geers I, Delanghe S, Delanghe JR.

Transthyretin levels in the vitreous correlate with change in visual acuity after vitrectomy.
Br J Ophthalmol 2009.

• Christensen UC, Kroyer K, Sander B, Jorgensen TM, Larsen M, la Cour M.

Macular morphology and visual acuity after macular hole surgery with or without internal limiting membrane peeling.
Br J Ophthalmol 2009.

• Gonzalez VH, Giuliari GP, Banda RM, Guel DA.

Intravitreal Injection of Pegaptanib Sodium for Proliferative Diabetic Retinopathy.
Br J Ophthalmol 2009.

• Landa G, Rosen RB.

New Patterns of Retinal Collateral Circulation are Exposed by the Retinal Functional Imager (RFI).
Br J Ophthalmol 2009.

• Fleming AD, Goatman KA, Philip S, Williams GJ, Prescott GJ, Scotland GS, McNamee P, Leese GP, Wykes W, Sharp PF, Olson JA.

The role of haemorrhage and exudate detection in automated grading of diabetic retinopathy.
Br J Ophthalmol 2009.

• Gupta A, Rogers S, Matthews BN.

Unilateral acute idiopathic maculopathy.
Br J Ophthalmol 2009;93:1073-4.

• Sebag J.

Vitreous: the resplendent enigma.
Br J Ophthalmol 2009;93:989-91.

• Wong D.

To peel or not to peel the internal limiting membrane: a question finally answered?
Br J Ophthalmol 2009;93:987-8.

• Bottos J, Miller RH, Belfort RN, Macedo AC, Toxoplasmosis Group U, Belfort R, Jr., Grigg ME.

Bilateral Retinochoroiditis Caused By An Atypical Strain Of Toxoplasma Gondii.
Br J Ophthalmol 2009.

• Lee HJ, Kee C.

Optical Coherence Tomography and Heidelberg Retina Tomography for Superior Segmental Optic Hypoplasia.
Br J Ophthalmol 2009.

• Chang JH, Raju R, Henderson TR, McCluskey PJ.

Incidence and pattern of acute anterior uveitis in Central Australia.
Br J Ophthalmol 2009.

• Tanna H, Dubis AM, Ayub N, Tait DM, Rha J, Stepien KE, Carroll J.

Retinal Imaging Using Commercial Broadband Optical Coherence Tomography.
Br J Ophthalmol 2009.

• Kim MJ, Lee EJ, Kim TW.

Peripapillary Retinal Nerve Fiber Layer Thickness Profile in Subjects with Myopia Measured Using the Stratus Optical Coherence Tomography.
Br J Ophthalmol 2009.

• Lenassi E, Jarc-Vidmar M, Hawlina M.

Pattern Electroretinography of Larger Stimulus Field Size and Spectral-Domain Optical Coherence Tomography in Patients with Stargardt Disease.
Br J Ophthalmol 2009.

• Keane PA, Mand PS, Liakopoulos S, Walsh AC, Sadda SR.

Accuracy of Retinal Thickness Measurements obtained with Cirrus Optical Coherence Tomography.
Br J Ophthalmol 2009.

• Gupta B, Laidlaw DA, Shah S, Wong R, Wren S.

Predicting visual success in macular hole surgery.
Br J Ophthalmol 2009.

• Fukuda S, Okamoto F, Yuasa M, Kunikata T, Okamoto Y, Hiraoka T, Oshika T.

Vision-Related Quality of Life and Visual Function in Patients undergoing Vitrectomy, Gas tamponade, and Cataract Surgery for Macular Hole.
Br J Ophthalmol 2009.

• Kokame GT, Yeung L, Lai JC.

Continuous anti-VEGF treatment with ranibizumab for polypoidal choroidal vasculopathy: an Interim 6-month report.
Br J Ophthalmol 2009.

• Frohman LP, Della Torre K, Turbin R, Bielory L.

Clinical Characteristics, Diagnostic Criteria, And Therapeutic Outcomes In Autoimmune Optic Neuropathy.
Br J Ophthalmol 2009.

• Lagreze WA, Feltgen N, Bach M, Jehle T.

Feasibility of intravitreal erythropoietin injections in humans.
Br J Ophthalmol 2009.

• Maeno T, Tano R, Takenaka H, Mano T.

Edaravone (MCI-186) is Effective as Free Radical Scavenger after Arteriovenous Sheathotomy for Treatment of Macular Oedema Associated with Branch Retinal Vein Occlusion.
Br J Ophthalmol 2009.

• van der Veen RL, Ostendorf S, Hendrikse F, Berendschot TT.

Macular pigment optical density relates to foveal thickness.
Eur J Ophthalmol 2009;19:836-41.

• Querques G, Bux AV, Delle Noci N.

Foveal geographic atrophy following intravitreal pegaptanib sodium (Macugen) for drusenoid pigment epithelium detachment.
Eur J Ophthalmol 2009;19:890-3.

• Battaglia-Parodi M, Sheth S, Papayannis A, Bandello F.

Treatment of serous pigment epithelium detachment with subthreshold micropulse diode laser photocoagulation: a case report.
Eur J Ophthalmol 2009;19:887-9.

• Henschel A, Spital G, Lommatzsch A, Pauleikhoff D.

Optical coherence tomography in neovascular age related macular degeneration compared to fluorescein angiography and visual acuity.
Eur J Ophthalmol 2009;19:831-5.

• Modarres M, Nazari H, Falavarjani KG, Naseripour M, Hashemi M, Parvaresh MM.

Intravitreal injection of bevacizumab before vitrectomy for proliferative diabetic retinopathy.
Eur J Ophthalmol 2009;19:848-52.

• Mino De Kaspar H, Ta CN, Froehlich SJ, Schaller UC, Engelbert M, Klauss V, Kampik A.

Prospective study of risk factors for conjunctival bacterial contamination in patients undergoing intraocular surgery.
Eur J Ophthalmol 2009;19:717-22.

• Wylegala E, Nowinska A.

Usefulness of anterior segment optical coherence tomography in Descemet membrane detachment.
Eur J Ophthalmol 2009;19:723-8.

• Ascaso FJ, Cruz N, Del Buey MA, Cristobal JA.

An unusual case of cocaine-induced maculopathy.
Eur J Ophthalmol 2009;19:880-2.

• Giammaria D, Cinque B, Di Lodovico D, Savastano MC, Cifone MG, Spadea L.

Anti-vascular endothelial growth factor activity in the bevacizumab and triamcinolone acetonide combination for intravitreal use.
Eur J Ophthalmol 2009;19:842-7.

• Cohen SY, Dubois L, Ayrault S, Quentel G.

T-shaped pigmentary changes in tilted disk syndrome.
Eur J Ophthalmol 2009;19:876-9.

• Accorinti M, Bruscolini A, Pirraglia MP, Liverani M, Caggiano C.

Toxoplasmic retinochoroiditis in an Italian referral center.
Eur J Ophthalmol 2009;19:824-30.

• Sadda SR, Liakopoulos S, Keane PA, Ongchin SC, Msutta S, Chang KT, Walsh AC.

Relationship between angiographic and optical coherence tomographic (OCT) parameters for quantifying choroidal neovascular lesions.
Graefes Arch Clin Exp Ophthalmol 2009.

• Hillenkamp J, Surguch V, Framme C, Gabel VP, Sachs HG.

Management of submacular hemorrhage with intravitreal versus subretinal injection of recombinant tissue plasminogen activator.
Graefes Arch Clin Exp Ophthalmol 2009.

• Hernandez-Pastor LJ, Ortega A, Garcia-Layana A, Giraldez J.

Cost-effectiveness of ranibizumab compared with pegaptanib in neovascular age-related macular degeneration.
Graefes Arch Clin Exp Ophthalmol 2009.

• Theelen T, Berendschot TT, Hoyng CB, Boon CJ, Klevering BJ.

Near-infrared reflectance imaging of neovascular age-related macular degeneration.
Graefes Arch Clin Exp Ophthalmol 2009.

• Klettner AK, Kruse ML, Meyer T, Wesch D, Kabelitz D, Roider J.

Different properties of VEGF-antagonists: Bevacizumab but not Ranibizumab accumulates in RPE cells.
Graefes Arch Clin Exp Ophthalmol 2009.

• Entezari M, Ramezani A, Ahmadieh H, Bakhtiari P, Yaseri M, Soltani K.

Cryotherapy of sclerotomy sites for prevention of late post-vitrectomy diabetic hemorrhage: a randomized clinical trial.
Graefes Arch Clin Exp Ophthalmol 2009.

• Lee JY, Du YE, Coki O, Flynn JT, Starren J, Chiang MF.

Parental perceptions toward digital imaging and telemedicine for retinopathy of prematurity management.
Graefes Arch Clin Exp Ophthalmol 2009.

• Pau H.

Hypothesis on the pathogenesis of retinopathy of prematurity-it is not VEGF alone but anatomical structures that are crucial.
Graefes Arch Clin Exp Ophthalmol 2009.

• Bourhis A, Girmens JF, Boni S, Pecha F, Favard C, Sahel JA, Paques M.

Imaging of macroaneurysms occurring during retinal vein occlusion and diabetic retinopathy by indocyanine green angiography and high resolution optical coherence tomography.
Graefes Arch Clin Exp Ophthalmol 2009.

• Shimura M, Yasuda K, Nakazawa T, Abe T, Shiono T, Iida T, Sakamoto T, Nishida K.

Panretinal photocoagulation induces pro-inflammatory cytokines and macular thickening in high-risk proliferative diabetic retinopathy.
Graefes Arch Clin Exp Ophthalmol 2009.

• Ladas ID, Kotsolis AI.

Fever after intravitreal anti-VEGF injections.
Graefes Arch Clin Exp Ophthalmol 2009.

• Grosso A, Panico C.

Tips and pitfalls in 23-gauge vitrectomy surgery : Does one size fits (almost) all?
Graefes Arch Clin Exp Ophthalmol 2009.

• Ach T, Hoeh AE, Schaal KB, Scheuerle AF, Dithmar S.

Predictive factors for changes in macular edema in intravitreal bevacizumab therapy of retinal vein occlusion.
Graefes Arch Clin Exp Ophthalmol 2009.

• Yip YW, Fok AC, Ngai JW, Lai RY, Lam DS, Lai TY.

Changes in first- and second-order multifocal electroretinography in idiopathic macular hole and their correlations with macular hole diameter and visual acuity.
Graefes Arch Clin Exp Ophthalmol 2009.

• Hoeh AE, Ach T, Schaal KB, Scheuerle AF, Dithmar S.

Long-term follow-up of OCT-guided bevacizumab treatment of macular edema due to retinal vein occlusion.
Graefes Arch Clin Exp Ophthalmol 2009.

• Rouvas A, Petrou P, Vergados I, Pechtasides D, Liarakos V, Mitsopoulou M, Ladas I.

Intravitreal ranibizumab (Lucentis) for treatment of central retinal vein occlusion: a prospective study.
Graefes Arch Clin Exp Ophthalmol 2009.

• Fortunato P, Pollazzi L, Baroni M, Evangelisti A, La Torre A.

Venous retinal flow reperfusion mechanisms following radial optic neurotomy with adjunctive intraocular triamcinolone in central retinal vein occlusion.
Graefes Arch Clin Exp Ophthalmol 2009.

• Mavrikakis I, Heran MK, White V, Rootman J.

The role of thrombosis as a mechanism of exacerbation in venous and combined venous lymphatic vascular malformations of the orbit.
Ophthalmology 2009;116:1216-24.

• Boulanger G, Weber M.

[Irvine Gass syndrome and central serous chorioretinopathy, pure coincidence or non fortuitous association? Report of three cases.].
J Fr Ophtalmol 2009.

• Viennet A, Glatre F, Bacin F.

[Interferon-related retinopathy in a man with chronic hepatitis C.].
J Fr Ophtalmol 2009;32:505-10.

• Wolff B, Masse H, Bonnel S, Sahel JA, Metge F.

[Vogt-Koyanagi-Harada syndrome: Angiographic and optical coherence tomography correlations.].
J Fr Ophtalmol 2009.

• Buestel C, Delyfer MN, Rougier MB, Korobelnik JF.

[Silicone oil and optical coherence tomography].
J Fr Ophtalmol 2009;32:529.

• Renard E, Chiquet C, Bouillet L, Romanet JP.

[Frosted branch angiitis revealing Behcet's disease.].
J Fr Ophtalmol 2009.

• Prenner JL, Kaiser R, Chang TS.

Perfused, but not leaking.
Ophthalmology 2009;116:1590, 1590 e1-2.

• Maberley D.

Photodynamic Therapy and Intravitreal Triamcinolone for Neovascular Age-Related Macular Degeneration A Randomized Clinical Trial.
Ophthalmology 2009.

• Yasuda M, Kiyohara Y, Hata Y, Arakawa S, Yonemoto K, Doi Y, Iida M, Ishibashi T.

Nine-Year Incidence and Risk Factors for Age-related Macular Degeneration in a Defined Japanese Population The Hisayama Study.
Ophthalmology 2009.

• Forooghian F, Agron E, Clemons TE, Ferris FL, 3rd, Chew EY.

Visual Acuity Outcomes after Cataract Surgery in Patients with Age-Related Macular Degeneration: Age-Related Eye Disease Study Report No. 27.
Ophthalmology 2009.

• Nguyen QD, Shah SM, Browning DJ, Hudson H, Sonkin P, Hariprasad SM, Kaiser P, Slakter JS, Haller J, Do DV, Mieler WF, Chu K, Yang K, Ingerman A, Vitti RL, Berliner AJ, Cedarbaum JM, Campochiaro PA.

A Phase I Study of Intravitreal Vascular Endothelial Growth Factor Trap-Eye in Patients with Neovascular Age-Related Macular Degeneration.
Ophthalmology 2009.

• Boyer DS, Heier JS, Brown DM, Francom SF, Ianchulev T, Rubio RG.

A Phase IIIb study to evaluate the safety of ranibizumab in subjects with neovascular age-related macular degeneration.
Ophthalmology 2009;116:1731-9.

• Bearelly S, Chau FY, Koreishi A, Stinnett SS, Izatt JA, Toth CA.

Spectral domain optical coherence tomography imaging of geographic atrophy margins.
Ophthalmology 2009;116:1762-9.

• Dadgostar H, Ventura AA, Chung JY, Sharma S, Kaiser PK.

Evaluation of injection frequency and visual acuity outcomes for ranibizumab monotherapy in exudative age-related macular degeneration.
Ophthalmology 2009;116:1740-7.

• Campochiaro PA, Choy DF, Do DV, Hafiz G, Shah SM, Nguyen QD, Rubio R, Arron JR.

Monitoring Ocular Drug Therapy by Analysis of Aqueous Samples.
Ophthalmology 2009.

• Moorthy S, Cheung N.

Cerebrovascular accidents and ranibizumab.
Ophthalmology 2009;116:1834-5; author reply 1835.

• Avgikos KN, Horgan SE, Sivaraj RR, Hu K.

Tachyphylaxis and bevacizumab.
Ophthalmology 2009;116:1831-2; author reply 1832.

• Beaumont PE, Kang HK.

Ranibizumab and nonocular hemorrhage.
Ophthalmology 2009;116:1593.

• Ziemssen F, Neuhann IM, Voelker M.

Tachyphylaxis and bevacizumab.
Ophthalmology 2009;116:1591-2; author reply 1592-3.

• Chavala SH, Farsiu S, Maldonado R, Wallace DK, Freedman SF, Toth CA.

Insights into Advanced Retinopathy of Prematurity Using Handheld Spectral Domain Optical Coherence Tomography Imaging.
Ophthalmology 2009.

• Kriechbaum K, Prager F, Geitzenauer W, Benesch T, Schutze C, Simader C, Schmidt-Erfurth U.

Association of Retinal Sensitivity and Morphology during Antiangiogenic Treatment of Retinal Vein Occlusion over One Year.
Ophthalmology 2009.

• Grauslund J, Green A, Sjolie AK.

Blindness in a 25-Year Follow-up of a Population-Based Cohort of Danish Type 1 Diabetic Patients.
Ophthalmology 2009.

• Narula R, Agarwal M, Chaudhary SP, Shroff C.

Diabetic macular edema.
Ophthalmology 2009;116:1833-4; author reply 1834.

• McGimpsey SJ, Woodside JV, Cardwell C, Cahill M, Chakravarthy U.

Homocysteine, methylenetetrahydrofolate reductase C677T polymorphism, and risk of retinal vein occlusion: a meta-analysis.
Ophthalmology 2009;116:1778-1787 e1.

• Sears JE.

Stimulating angiogenesis to prevent ischemic retinopathy.
Ophthalmology 2009;116:1597-8.

• Sato T, Kusaka S, Shimojo H, Fujikado T.

Simultaneous Analyses of Vitreous Levels of 27 Cytokines in Eyes with Retinopathy of Prematurity.
Ophthalmology 2009.

• Morini C, Capozzi P, Boenzi S, Rizzo C, Santorelli FM, Dionisi-Vici C.

Retinal degeneration.
Ophthalmology 2009;116:1593, 1593 e1.

• Sloan FA, Grossman DS, Lee PP.

Effects of receipt of guideline-recommended care on onset of diabetic retinopathy and its progression.
Ophthalmology 2009;116:1515-21, 1521 e1-3.

• Watanabe A, Arimoto S, Nishi O.

Correlation between metamorphopsia and epiretinal membrane optical coherence tomography findings.
Ophthalmology 2009;116:1788-93.

• Dupas B, Tadayoni R, Erginay A, Massin P, Gaudric A.

Subfoveal deposits secondary to idiopathic epiretinal membranes.
Ophthalmology 2009;116:1794-8.

• Ishihara K, Hangai M, Kita M, Yoshimura N.

Acute Vogt-Koyanagi-Harada disease in enhanced spectral-domain optical coherence tomography.
Ophthalmology 2009;116:1799-807.

• Ip MS, Oden NL, Scott IU, VanVeldhuisen PC, Blodi BA, Figueroa M, Antoszyk A, Elman M.

SCORE Study report 3: study design and baseline characteristics.
Ophthalmology 2009;116:1770-1777 e1.

• Byeon SH, Kang SY.

OCT Interpretation.
Ophthalmology 2009;116:1419, 1419 e1-2; author reply 1419-20.

• McCannel CA, Ensminger JL, Diehl NN, Hodge DN.

Population-based incidence of macular holes.
Ophthalmology 2009;116:1366-9.

• Shields JA, Eagle RC, Jr., Shields CL, Brown GC, Lally SE.

Malignant Transformation of Congenital Hypertrophy of the Retinal Pigment Epithelium.
Ophthalmology 2009.

• Lane AM, Egan KM, Harmon D, Holbrook A, Munzenrider JE, Gragoudas ES.

Adjuvant Interferon Therapy for Patients with Uveal Melanoma at High Risk of Metastasis.
Ophthalmology 2009.

• Christensen UC, Kroyer K, Sander B, Larsen M, Cour ML.

Prognostic Significance of Delayed Structural Recovery after Macular Hole Surgery.
Ophthalmology 2009.

• Fernandez-Buenaga R, Rebolleda G, Munoz-Negrete FJ, Contreras I, Casas-Llera P.

Macular thickness.
Ophthalmology 2009;116:1587, 1587 e1-3.

• Ney JJ, Volpe NJ, Liu GT, Balcer LJ, Moster ML, Galetta SL.

Functional visual loss in idiopathic intracranial hypertension.
Ophthalmology 2009;116:1808-1813 e1.

• Hu AY, Bourges JL, Shah SP, Gupta A, Gonzales CR, Oliver SC, Schwartz SD.

Endophthalmitis after pars plana vitrectomy a 20- and 25-gauge comparison.
Ophthalmology 2009;116:1360-5.

• Nguyen QD, Shah SM, Heier JS, Do DV, Lim J, Boyer D, Abraham P, Campochiaro PA.

Primary End Point (Six Months) Results of the Ranibizumab for Edema of the mAcula in Diabetes (READ-2) Study.
Ophthalmology 2009.

• Vasconcelos-Santos DV, Machado Azevedo DO, Campos WR, Orefice F, Queiroz-Andrade GM, Carellos EV, Castro Romanelli RM, Januario JN, Resende LM, Martins-Filho OA, de Aguiar Vasconcelos Carneiro AC, Almeida Vitor RW, Caiaffa WT.

Congenital Toxoplasmosis in Southeastern Brazil: Results of Early Ophthalmologic Examination of a Large Cohort of Neonates.
Ophthalmology 2009.

• Solomon SD, Jefferys JL, Hawkins BS, Bressler NM, Bressler SB.

Risk factors for second eye progression to advanced age-related macular degeneration: SST report No. 21 Submacular Surgery Trials Research Group.
Retina 2009;29:1080-90.

• Kim KS, Lee WK.

Photodynamic Therapy with Verteporfin for Avascular Serous Pigment Epithelial Detachment in Elderly Koreans.
Retina 2009.

• Leng T, Rosenfeld PJ, Gregori G, Puliafito CA, Punjabi OS.

Spectral domain optical coherence tomography characteristics of cuticular drusen.
Retina 2009;29:988-93.

• Forte R, Cennamo G, Vecchio EC, Tenore R, Aufiero B, de Crecchio G.

Bevacizumab in macular edema: functional and anatomic changes in a prospective case series.
Retina 2009;29:941-8.

• Heier JS.

Pathology beyond neovascularization: new targets in age-related macular degeneration.
Retina 2009;29:S39-41.

• Brucker AJ.

Age-related macular degeneration.
Retina 2009;29:S2-4.

• Levine JP, Marcus I, Sorenson JA, Spaide RF, Cooney MJ, Freund KB.

Macular hemorrhage in neovascular age-related macular degeneration after stabilization with antiangiogenic therapy.
Retina 2009;29:1074-9.

• Cohen SY.

Anti-VEGF drugs as the 2009 first-line therapy for choroidal neovascularization in pathologic myopia.
Retina 2009;29:1062-6.

• Stepien KE, Rosenfeld PJ, Puliafito CA, Feuer W, Shi W, Al-Attar L, Dubovy SR, Murray TG, Davis JL, Lee WH, Schwartz SG, Smiddy WE, Berrocal AM, Flynn HW, Jr.

Comparison of intravitreal bevacizumab followed by ranibizumab for the treatment of neovascular age-related macular degeneration.
Retina 2009;29:1067-73.

• Augustin A.

Triple therapy for age-related macular degeneration.
Retina 2009;29:S8-11.

• Patel S.

Combination therapy for age-related macular degeneration.
Retina 2009;29:S45-8.

• Busch T.

Approaches toward combining photodynamic therapy with pharmaceuticals that alter vascular microenvironment.
Retina 2009;29:S36-8.

• Kuppermann BD.

Drug delivery strategies for combination ophthalmic treatments.
Retina 2009;29:S24-6.

• Kaiser PK.

Strategies for inhibiting vascular endothelial growth factor.
Retina 2009;29:S15-7.

• Arias L, Ruiz-Moreno JM, Gomez-Ulla F, Fernandez M, Montero J.

A 1-Year Retrospective Review of Ranibizumab for Naive Nonsubfoveal Choroidal Neovascularization Secondary to Age-Related Macular Degeneration.
Retina 2009.

• Das R, Shi Y, Silvestri G, Chakravarthy U.

Distortion maps from preferential hyperacuity perimetry are helpful in monitoring functional response to Lucentis therapy.
Retina 2009;29:1013-8.

• Lo Giudice G, Gismondi M, De Belvis V, Cian R, Tavolato M, Galan A.

Single-session photodynamic therapy combined with intravitreal bevacizumab for retinal angiomatous proliferation.
Retina 2009;29:949-55.

• Peyman GA, Lad EM, Moshfeghi DM.

Intravitreal injection of therapeutic agents.
Retina 2009;29:875-912.

• Spaide RF.

Rationale for combination therapy in age-related macular degeneration.
Retina 2009;29:S5-7.

• Kaiser PK.

Overview of radiation trials for age-related macular degeneration.
Retina 2009;29:S34-5.

• Cidlowski JA.

Glucocorticoids and their actions in cells.
Retina 2009;29:S21-3.

• Markabi S.

Combination therapy from the regulatory perspective.
Retina 2009;29:S12-4.

• Sunness JS, Schartz RB, Thompson JT, Sjaarda RN, Elman MJ.

Patterns of referral of retinal patients for low vision intervention in the anti-VEGF era.
Retina 2009;29:1036-9.

• Peyman GA, Fiscella R, Conway M.

Combination angiostatic therapies: current status.
Retina 2009;29:S18-20.

• Brucker AJ, Spaide RJ.

Supplement on combination therapy.
Retina 2009;29:S1.

• Huang YH, Yeh PT, Chen MS, Yang CH, Yang CM.

Intravitreal bevacizumab and panretinal photocoagulation for proliferative diabetic retinopathy associated with vitreous hemorrhage.
Retina 2009;29:1134-40.

• Gaucher D, Fortunato P, Lecleire-Collet A, Bourcier T, Speeg-Schatz C, Tadayoni R, Massin P.

Spontaneous Resolution of Macular Edema after Panretinal Photocoagulation in Florid Proliferative Diabetic Retinopathy.
Retina 2009.

• Otani A, Yoshimura N.

Re: The potential of pluripotent cells in vitreoretinal diseases.
Retina 2009;29:1055-6; author reply 1056.

• Uparkar M.

Re: Macular structure and vision of patients with macular heterotopia secondary to retinopathy of prematurity.
Retina 2009;29:1054; author reply 1054.

• Nagpal PN, Mehta V, Nagpal K, Nagpal M.

Re: Surgical treatment of a juxtapapillary retinal hemangioma.
Retina 2009;29:1054-5; author reply 1055.

• Lima LH, Cella W, Greenstein VC, Wang NK, Busuioc M, Smith RT, Yannuzzi LA, Tsang SH.

Structural assessment of hyperautofluorescent ring in patients with retinitis pigmentosa.
Retina 2009;29:1025-31.

• Huang J, Liu X, Wu Z, Xiao H, Dustin L, Sadda S.

Macular thickness measurements in normal eyes with time-domain and Fourier-domain optical coherence tomography.
Retina 2009;29:980-7.

• Hattenbach LO, Friedrich Arndt C, Lerche R, Scharrer I, Baatz H, Margaron F, Richard G, Behrens-Baumann W, Ohrloff C.

Retinal vein occlusion and low-dose fibrinolytic therapy (R.O.L.F.): a prospective, randomized, controlled multicenter study of low-dose recombinant tissue plasminogen activator versus hemodilution in retinal vein occlusion.
Retina 2009;29:932-40.

• Lo WR, Kim SJ, Aaberg TM, Sr., Bergstrom C, Srivastava SK, Yan J, Martin DF, Hubbard GB, 3rd.

Visual outcomes and incidence of recurrent vitreous hemorrhage after vitrectomy in diabetic eyes pretreated with bevacizumab (avastin).
Retina 2009;29:926-31.

• Gregori NZ, Rattan GH, Rosenfeld PJ, Puliafito CA, Feuer W, Flynn HW, Jr., Berrocal AM, Al-Attar L, Dubovy S, Smiddy WE, Schwartz SG, Lee WH, Murray TG.

Safety and efficacy of intravitreal bevacizumab (avastin) for the management of branch and hemiretinal vein occlusion.
Retina 2009;29:913-25.

• Sebag J.

Pharmacologic vitreolysis--premise and promise of the first decade.
Retina 2009;29:871-4.

• Querques G, Bux AV, Martinelli D, Iaculli C, Del Curatolo MV, Noci ND.

Short-Term Fluctuation of Diabetic Macular Edema after Intravitreal Ranibizumab Injection.
Retina 2009.

• Zhao MW, Zhou P, Xiao HX, Lv YS, Li CA, Liu GD, Li XX.

Photodynamic therapy for acute central serous chorioretinopathy: the safe effective lowest dose of verteporfin.
Retina 2009;29:1155-61.

• Seth RK, Salim S, Shields MB, Adelman RA.

Assessment of optic nerve cup-to-disk ratio changes in patients receiving multiple intravitreal injections of antivascular endothelial growth factor agents.
Retina 2009;29:956-9.

• Kweon EY, Ahn M, Lee DW, You IC, Kim MJ, Cho NC.

Operating Microscope Light-Induced Phototoxic Maculopathy after Transscleral Sutured Posterior Chamber Intraocular Lens Implantation.
Retina 2009.

• Yamamoto T, Kamei M, Sakaguchi H, Oshima Y, Ikuno Y, Gomi F, Ohji M, Tano Y.

Comparison of surgical treatments for central retinal vein occlusion; RON vs. cannulation of tissue plasminogen activator into the retinal vein.
Retina 2009;29:1167-74.

• Kondo M, Kondo N, Ito Y, Kachi S, Kikuchi M, Yasuma TR, Ota I, Miyake K, Terasaki H.

INTRAVITREAL INJECTION OF BEVACIZUMAB FOR MACULAR EDEMA SECONDARY TO BRANCH RETINAL VEIN OCCLUSION: Results After 12 Months and Multiple Regression Analysis.
Retina 2009.

• Uemoto R, Nakasato S, Mizuki N.

New technique for inserting 27-gauge twinlight chandelier illumination fibers into the eye using intravenous cannula.
Retina 2009;29:1040-2.

• El-Dairi M, Bhatti MT, Vaphiades MS.

A shot of adrenaline.
Surv Ophthalmol 2009;54:618-24.